In contrast, EZH2 inhibition enhanced cell proliferation and reduced apoptosis in AML cells, in line with myeloid cell leukemogenesis and chemotherapy resistance with reduced EZH2 expression or function [269]. Here, EZH2 is linked to acute myeloid leukemia.